Fundz

RevolKa Ltd. raised 250 million JPY (US$1.7 Million) in a Series A extension funding led by D3 LLC and DEEPCORE Inc. to accelerate drug discovery programs.

PRIVATEAug 30, 2024

Amount Raised

¥250 Million

Round Type

Series A

SendaiBiotechnologyArtificial Intelligence

Investors

Deepcore Inc.D3 Llc

Description

RevolKa Ltd. has announced the closing of a total of 250 million JPY (US$1.7M) in Series A extension funding, with 100 million JPY (US$0.7M) as the latest financing. The funds will be used to advance the company’s drug discovery and development activities for rare diseases.

Who else raised in Biotechnology and Artificial Intelligence around the same time

Companies in the same sectors as RevolKa that raised within 45 days of this round, from Fundz verified event records.

  • Shuttle Pharmaceutical Holdings raised $790K (Seed) on October 14, 2024.
  • Basecamp Research raised $60M (Series B) on October 9, 2024.
  • Ai Health Highway raised $1M (Pre-Series A) on October 4, 2024.
  • Medeloop raised $15M on October 4, 2024.
  • Integrated Biosciences raised $17M (Seed) on October 3, 2024.
  • SURGAR raised $12M (Funding Round) on September 26, 2024.

Who to call at RevolKa, and when

A new round usually means RevolKa is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RevolKa raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RevolKa, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RevolKa. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RevolKa

Location

Sendai, Miyagi Prefecture, Japan

About

RevolKa is a pioneer of next-generation protein engineering. We are committed to the discovery and development of innovative proteins by leveraging our proprietary artificial intelligence-integrated directed protein evolution technology, called aiProtein®. RevolKa is open to research collaboration opportunities with partners and also co-development of our internal assets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RevolKa raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for RevolKa's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

RevolKa raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.